This result is consistent with literature reports that reflect a higher upgrade rate for ADH, both in relation to its accessible and more frequent DM detection [19], but especially for its pathological similarities to DCIS [23,24]. This evidence concerns the gene AVP and ductal breast carcinoma in situ.